Lactoylglutathione lyase
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 1–184 Chain B; UniProt 1–184 | Not recorded | ZN ZINC ION × 2 A1L5R 1-(4-hydroxyphenyl)-3-[2-methoxy-3,4-bis(oxidanyl)phenyl]prop-2-en-1-one × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Sodium chloride, 0.1 M Bis-Tris, 25%(w/v) PEG 3350 | Resolution 2.08 Å R-free 0.234 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 9KEE | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1BH5 HUMAN GLYOXALASE I Q33E, E172Q DOUBLE MUTANT Deposited 1998-06-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–183(183 aa)
Chain B
1–183(183 aa)
|
Mutation:Q33E, E172Q Mutation:Q33E, E172Q | ZN ZINC ION × 2 GTX S-HEXYLGLUTATHIONE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;PROTEIN WAS CRYSTALLISED FROM PEG 2000 MONOMETHLY ETHER 50 MM MES PH 5.8, 0.1M NACL
|
Resolution 2.20 Å R-free 0.250 |
| 1BH5 HUMAN GLYOXALASE I Q33E, E172Q DOUBLE MUTANT Deposited 1998-06-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–183(183 aa)
Chain D
1–183(183 aa)
|
Mutation:Q33E, E172Q Mutation:Q33E, E172Q | ZN ZINC ION × 2 GTX S-HEXYLGLUTATHIONE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;PROTEIN WAS CRYSTALLISED FROM PEG 2000 MONOMETHLY ETHER 50 MM MES PH 5.8, 0.1M NACL
|
Resolution 2.20 Å R-free 0.250 |
| 1FRO HUMAN GLYOXALASE I WITH BENZYL-GLUTATHIONE INHIBITOR Deposited 1997-02-25 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
2–184(183 aa)
Chain B
2–184(183 aa)
|
Not recorded | ZN ZINC ION × 2 GSB S-BENZYL-GLUTATHIONE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;pH 5.8
|
Resolution 2.20 Å R-free 0.234 |
| 1FRO HUMAN GLYOXALASE I WITH BENZYL-GLUTATHIONE INHIBITOR Deposited 1997-02-25 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
2–184(183 aa)
Chain D
2–184(183 aa)
|
Not recorded | ZN ZINC ION × 2 GSB S-BENZYL-GLUTATHIONE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;pH 5.8
|
Resolution 2.20 Å R-free 0.234 |
| 1QIN HUMAN GLYOXALASE I COMPLEXED WITH S-(N-HYDROXY-N-P-IODOPHENYLCARBAMOYL) GLUTATHIONE Deposited 1999-06-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–183(183 aa)
Chain B
1–183(183 aa)
|
Not recorded | ZN ZINC ION × 2 GIP S-(N-HYDROXY-N-IODOPHENYLCARBAMOYL)GLUTATHIONE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;PROTEIN WAS CRYSTALLISED BY EQILLABRATION AGAINST PEG 2000 MONOMETHLY ETHER,
50 MM MES PH 5.8, 0.1M NACL. HIPC-GSH WAS PRESENT IN THE PROTEIN SOLUTION
|
Resolution 2.00 Å R-free 0.210 |
| 1QIP HUMAN GLYOXALASE I COMPLEXED WITH S-P-NITROBENZYLOXYCARBONYLGLUTATHIONE Deposited 1999-06-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–183(183 aa)
Chain B
1–183(183 aa)
|
Not recorded | ZN ZINC ION × 2 GNB S-P-NITROBENZYLOXYCARBONYLGLUTATHIONE × 2 BME BETA-MERCAPTOETHANOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;PROTEIN WAS CRYSTALLISED BY EQILLABRATION AGAINST PEG 2000 MONOMETHLY ETHER,
50 MM MES PH 5.8, 0.1M NACL THEN SOAKED IN 10MM NBC-GSH
|
Resolution 1.72 Å R-free 0.210 |
| 1QIP HUMAN GLYOXALASE I COMPLEXED WITH S-P-NITROBENZYLOXYCARBONYLGLUTATHIONE Deposited 1999-06-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–183(183 aa)
Chain D
1–183(183 aa)
|
Not recorded | ZN ZINC ION × 2 GNB S-P-NITROBENZYLOXYCARBONYLGLUTATHIONE × 2 BME BETA-MERCAPTOETHANOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;PROTEIN WAS CRYSTALLISED BY EQILLABRATION AGAINST PEG 2000 MONOMETHLY ETHER,
50 MM MES PH 5.8, 0.1M NACL THEN SOAKED IN 10MM NBC-GSH
|
Resolution 1.72 Å R-free 0.210 |
| 3VW9 Human Glyoxalase I with an N-hydroxypyridone inhibitor Deposited 2012-08-10 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 HPJ 1-hydroxy-6-[1-(3-methoxypropyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-4-phenylpyridin-2(1H)-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;25%(w/v) PEG 2000 MME, 10%(v/v) Glycerol, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K
|
Resolution 1.47 Å R-free 0.193 |
| 3W0T Human Glyoxalase I with an N-hydroxypyridone derivative inhibitor Deposited 2012-11-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 HPU N-[3-(1-hydroxy-6-oxo-4-phenyl-1,6-dihydropyridin-2-yl)phenyl]methanesulfonamide × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;33% (w/v) PEG 2000 MME, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K
|
Resolution 1.35 Å R-free 0.197 |
| 3W0T Human Glyoxalase I with an N-hydroxypyridone derivative inhibitor Deposited 2012-11-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–184(184 aa)
Chain D
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 HPU N-[3-(1-hydroxy-6-oxo-4-phenyl-1,6-dihydropyridin-2-yl)phenyl]methanesulfonamide × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;33% (w/v) PEG 2000 MME, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K
|
Resolution 1.35 Å R-free 0.197 |
| 3W0U human Glyoxalase I with an N-hydroxypyridone inhibitor Deposited 2012-11-02 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 HPW N-[3-(1-Hydroxy-6-oxo-4-phenyl-1,6-dihydro-pyridin-2-yl)-5-methanesulfonylamino-phenyl]-methanesulfonamide × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;25% (w/v) PEG 2000 MME, 10%(v/v) Glycerol, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K
|
Resolution 1.70 Å R-free 0.242 |
| 7WSZ human glyoxalase I (with C-ter His tag) in glycerol-bound form Deposited 2022-02-03 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 GOL GLYCEROL × 4 BO3 BORIC ACID × 3 IMD IMIDAZOLE × 1 BME BETA-MERCAPTOETHANOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M MIB (sodium malonate, imidazole, and boric acid), 25% PEG1500
|
Resolution 1.52 Å R-free 0.187 |
| 7WT0 human glyoxalase I (with C-ter His tag) in complex with TLSC702 Deposited 2022-02-03 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 5ZO (~{E})-3-(1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)but-3-enoic acid × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M MgCl2, 0.1 M Bis-Tris, 25% PEG3350
|
Resolution 2.00 Å R-free 0.222 |
| 7WT1 human glyoxalase I (with C-ter His tag) in inhibitor-free form Deposited 2022-02-03 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M NaCl, 0.1 M MES-NaOH, 25% PEG3350
|
Resolution 1.85 Å R-free 0.230 |
| 7WT2 human glyoxalase I in complex with TLSC702 Deposited 2022-02-03 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 5ZO (~{E})-3-(1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)but-3-enoic acid × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M NaCl, 0.1 M Bis-Tris, 25% PEG3350
|
Resolution 2.00 Å R-free 0.228 |
| 9KEG human glyoxalase I (with C-ter His tag) in complex with licochalcone B, form 2 Deposited 2024-11-05 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | A1L5R 1-(4-hydroxyphenyl)-3-[2-methoxy-3,4-bis(oxidanyl)phenyl]prop-2-en-1-one × 2 PG4 TETRAETHYLENE GLYCOL × 2 BME BETA-MERCAPTOETHANOL × 3 ZN ZINC ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.8;293 K;0.2 M Sodium chloride, 0.1 M MES, 25%(w/v) PEG 3350
|
Resolution 1.80 Å R-free 0.239 |
| 9KEH human glyoxalase I (with C-ter His tag) in complex with licochalcone B and GSH, form 3 Deposited 2024-11-05 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 A1L5R 1-(4-hydroxyphenyl)-3-[2-methoxy-3,4-bis(oxidanyl)phenyl]prop-2-en-1-one × 2 PG4 TETRAETHYLENE GLYCOL × 2 GSH Glutathione × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Sodium chloride, 0.1 M Bis-Tris, 25%(w/v) PEG 3350
|
Resolution 1.72 Å R-free 0.193 |
| 9KEI human glyoxalase I (with C-ter His tag) in complex with licochalcone B, form 4 Deposited 2024-11-05 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | A1L5R 1-(4-hydroxyphenyl)-3-[2-methoxy-3,4-bis(oxidanyl)phenyl]prop-2-en-1-one × 2 PGE TRIETHYLENE GLYCOL × 2 ZN ZINC ION × 2 BME BETA-MERCAPTOETHANOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.8;293 K;0.2 M Sodium chloride, 0.1 M MES, 25%(w/v) PEG 3350
|
Resolution 1.81 Å R-free 0.238 |
| 9KEK human glyoxalase I (with C-ter His tag) in complex with piceatannol Deposited 2024-11-05 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–184(184 aa)
Chain B
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 PIT PICEATANNOL × 2 PG4 TETRAETHYLENE GLYCOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Sodium chloride, 0.1 M Bis-Tris, 25%(w/v) PEG 3350
|
Resolution 2.11 Å R-free 0.233 |
| 9KEK human glyoxalase I (with C-ter His tag) in complex with piceatannol Deposited 2024-11-05 | Different ligand/ion Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–184(184 aa)
Chain D
1–184(184 aa)
|
Not recorded | ZN ZINC ION × 2 PIT PICEATANNOL × 1 PG4 TETRAETHYLENE GLYCOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Sodium chloride, 0.1 M Bis-Tris, 25%(w/v) PEG 3350
|
Resolution 2.11 Å R-free 0.233 |
15 other PDB entries and 20 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | LGUL_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–184; UniProt 1–184 Author chain B; PDBConstruct 1–184; UniProt 1–184 |